News in the Life Sciences Industry |
|
| Results 41 - 60 out of 500 displayed. | |
| « 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » | |
Global Hepatitis Test Solution/Diagnosis Market to 2023 with Roche, Abbott Laboratories, Bio-Rad, Siemens, DiaSorin, QIAGEN, Danaher, bioMrieux, and Grifols Dominating |
DUBLIN, Dec. 14, 2018 /PRNewswire/ -- Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
Surgical Retractor Market Worth $2.5 Billion by 2023 - Exclusive Report by MarketsandMarkets(TM) |
CHICAGO, December 14, 2018 /PRNewswire/ -- Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
Healogics, Inc. Names David Jollow as Chief Information Security Officer |
JACKSONVILLE, Fla., Dec. 14, 2018 /PRNewswire/ -- Healogics, the nation's largest provider of advanced chronic wound care services, today announced that it has appointed David Jollow to serve as Chief Information Security Officer. In this role, Jollow will conduct assessments of current IT security... Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
| Related companies: Healogics, Inc |
Global Nebulization Masks Market Report 2019-2023 |
DUBLIN, Dec. 14, 2018 /PRNewswire/ -- Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
Heart on Southwest Airlines flight provided life-saving gifts |
VIRGINIA BEACH, Va., Dec. 14, 2018 /PRNewswire/ -- The heart that was inadvertently left on board a Southwest Airlines plane in Seattle on Sunday, Dec. 9, made it to LifeNet Health's Pacific Northwest facility in time to provide two potentially life-saving cardiac tissue grafts. Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
| Related companies: LifeNet Health |
Lupus Research Alliance Applauds FDA's Fast Track Designation to Develop Baricitinib for Lupus |
NEW YORK, Dec. 14, 2018 /PRNewswire/ -- The Lupus Research Alliance is pleased to share good news about a potential new treatment for systemic lupus erythematosus (SLE). Today, Eli Lilly and Company and Incyte Corporation announced that... Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
| Related companies: Lupus Research Alliance |
Astellas Acquires Potenza Therapeutics |
TOKYO and NORTHBROOK, Ill., Dec. 14, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it exercised, and closed on its exclusive option to acquire Potenza Therapeutics, Inc. ("Potenza") on December 13, 2018, U.S. Eastern... Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
INVESTOR ALERT: Ademi & O'Reilly, LLP Investigates Whether Johnson & Johnson (JNJ) Violated Securities Laws |
MILWAUKEE, Dec. 14, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP announces an investigation of Johnson & Johnson (NYSE: JNJ) for possible violations of securities laws. Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
| Related companies: Johnson & Johnson |
TerrAscend Announces Agreement for US$75 Million Credit Facility |
- Credit facility to support initiation of TerrAscend's US acquisition strategy - Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
| Related companies: TerrAscend Corp. |
Sensorion Announces Positive Topline Results From Seliforant Phase 2a Study |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
| Related companies: Sensorion S.A |
Rule 2.9 Announcement |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
| Related companies: ShangPharma Corp. (SHP) | Shire plc |
FIT Biotech Oy: FIT Biotech's financial calendar and Annual General Meeting in 2019 |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
| Related companies: FIT Biotech Oy |
Santhera Provides Update on the Share Placement |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
| Related companies: Zealand Pharma A/S |
Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
The Ensign Group, Inc. Increases Quarterly Dividend to $0.0475 Per Share |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
The Finnish Competition and Consumer Authority has given the final approval for the transaction between Terveystalo and Attendo which is intended to be completed on 28 December 2018 |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 14 Dec 2018 |
bioLIVE China 2019 to be Newly Upgraded to Lead the Development of Bio-Pharma Technology in Asia |
SHANGHAI, Dec. 14, 2018 /PRNewswire/ -- The bio-pharma industry has entered the new stage of rapid development in recent years with the continuous development of cutting-edge biological technology and the emergence and marketing of new targeted drugs and cell therapies. From the perspective of... Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
FICCI Medical Travel Value Awards 2018 Given to 17 Hospitals & Healthcare Service Providers |
GREATER NOIDA, India, December 14, 2018 /PRNewswire/ -- Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance |
STOCKHOLM, Dec. 14, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that BioArctic and its partner AbbVie (NYSE: ABBV) have received U.S. Federal Trade Commission (FTC) clearance to license BioArctic's alpha-synuclein antibody portfolio for Parkinson's disease... Read more ›› |
| By: PR Newswire Association LLC. - 14 Dec 2018 |
| Related companies: BioArctic AB |
| « 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |